These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 22860286)
1. Advances in the development of improved animal-free models for use in breast cancer biomedical research. Roberts S; Speirs V Biophys Rev; 2017 Aug; 9(4):321-327. PubMed ID: 28748520 [TBL] [Abstract][Full Text] [Related]
2. What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? Manning J; O'Malley D J Muscle Res Cell Motil; 2015 Apr; 36(2):155-67. PubMed ID: 25669899 [TBL] [Abstract][Full Text] [Related]
3. Research from the bedside to the lab bench & back. White RA; Silvey M; Logsdon DP Mo Med; 2012; 109(3):195-8. PubMed ID: 22860286 [TBL] [Abstract][Full Text] [Related]
9. Update on iron chelators in thalassemia. Neufeld EJ Hematology Am Soc Hematol Educ Program; 2010; 2010():451-5. PubMed ID: 21239834 [TBL] [Abstract][Full Text] [Related]
10. Iron-chelating therapy for transfusional iron overload. Brittenham GM N Engl J Med; 2011 Jan; 364(2):146-56. PubMed ID: 21226580 [TBL] [Abstract][Full Text] [Related]
11. Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model. Heruth DP; Hawkins T; Logsdon DP; Gibson MI; Sokolovsky IV; Nsumu NN; Major SL; Fegley B; Woods GM; Lewing KB; Neville KA; Cornetta K; Peterson KR; White RA Genomics; 2010 Nov; 96(5):303-7. PubMed ID: 20691777 [TBL] [Abstract][Full Text] [Related]
12. Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicities. Kontoghiorghes GJ Expert Opin Drug Saf; 2010 Jul; 9(4):633-41. PubMed ID: 20553089 [TBL] [Abstract][Full Text] [Related]
13. Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption. Kontoghiorghes GJ; Spyrou A; Kolnagou A Hemoglobin; 2010 Jun; 34(3):251-64. PubMed ID: 20524815 [TBL] [Abstract][Full Text] [Related]
14. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Economou M; Printza N; Teli A; Tzimouli V; Tsatra I; Papachristou F; Athanassiou-Metaxa M Acta Haematol; 2010; 123(3):148-52. PubMed ID: 20185899 [TBL] [Abstract][Full Text] [Related]